Novartis Investigative Site

West Midlands, Birmingham B4 6NH

1 studies enrolling now · 5 studies all time

What they study most

ALK-activated Tumors, Familial Hypercholesterolemia - Heterozygous, Liver Transplant, Multiple Sclerosis, PIK3CA-related Overgrowth Spectrum (PROS), Renal Function

Studies at this site

• Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia — Recruiting now
• Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis — Running, not enrolling
• Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum — Running, not enrolling
• Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) — Completed
• Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. — Completed